AU Stock MarketDetailed Quotes

ACRO Acrux Ltd

Watchlist
  • 0.001
  • 0.0000.00%
20min DelayMarket Closed Apr 10 16:00 AET
407.32KMarket Cap0.00P/E (Static)

About Acrux Ltd Company

Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.

Company Profile

SymbolACRO
Company NameAcrux Ltd
Founded1998
MarketASX
Employees36
Fiscal Year Ends06-30
Address103-113 Stanley Street West Melbourne
CityMelbourne
CountryAustralia
Zip Code3003
Phone+61 383790100
Share RegistryMUFG CORPORATE MARKETS (AU) LIMITED Tower 4, 727 Collins Street, DOCKLANDS, VIC, AUSTRALIA, 3008 1300 554 474

Company Executives

  • Name
  • Position
  • Salary
  • Michael John Kotsanis
  • Chief Executive Officer,Managing Director
  • --
  • Ross Dobinson
  • Non-Executive Chairman,Non-Executive Director
  • --
  • Timothy Oldham
  • Non-Executive Director
  • --
  • Geoffrey E.D Brooke
  • Non-Executive Director
  • --
  • Donald Charles Brumley
  • Non-Executive Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More